Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.38 - $0.53 $15,111 - $21,075
-39,766 Reduced 32.53%
82,472 $31,000
Q2 2022

Aug 15, 2022

BUY
$0.32 - $0.74 $39,116 - $90,456
122,238 New
122,238 $56,000
Q1 2022

May 16, 2022

SELL
$0.41 - $0.7 $19,912 - $33,997
-48,568 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.53 - $1.03 $25,741 - $50,025
48,568 New
48,568 $28,000
Q3 2021

Nov 15, 2021

SELL
$1.0 - $1.18 $111,383 - $131,431
-111,383 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.01 - $1.58 $327,503 - $512,332
-324,261 Reduced 74.43%
111,383 $134,000
Q1 2021

May 17, 2021

BUY
$1.23 - $5.98 $123,392 - $599,907
100,319 Added 29.92%
435,644 $566,000
Q4 2020

Feb 16, 2021

BUY
$2.09 - $5.18 $236,907 - $587,168
113,353 Added 51.07%
335,325 $1.23 Million
Q3 2020

Nov 16, 2020

SELL
$1.71 - $2.68 $659,851 - $1.03 Million
-385,878 Reduced 63.48%
221,972 $475,000
Q2 2020

Aug 14, 2020

BUY
$1.23 - $2.12 $137,489 - $236,973
111,780 Added 22.53%
607,850 $1.09 Million
Q1 2020

May 14, 2020

SELL
$1.06 - $2.15 $34,967 - $70,924
-32,988 Reduced 6.24%
496,070 $655,000
Q4 2019

Feb 14, 2020

SELL
$1.45 - $2.79 $598,963 - $1.15 Million
-413,078 Reduced 43.84%
529,058 $963,000
Q3 2019

Nov 14, 2019

SELL
$2.12 - $3.31 $34,840 - $54,396
-16,434 Reduced 1.71%
942,136 $2.72 Million
Q2 2019

Aug 15, 2019

BUY
$2.37 - $3.97 $1.1 Million - $1.85 Million
464,876 Added 94.16%
958,570 $2.56 Million
Q2 2019

Aug 14, 2019

SELL
$2.37 - $3.97 $256,751 - $430,085
-108,334 Reduced 17.99%
493,694 $51 Million
Q1 2019

May 14, 2019

SELL
$2.33 - $3.79 $1,423 - $2,315
-611 Reduced 0.1%
602,028 $1.54 Million
Q4 2018

Feb 14, 2019

BUY
$2.77 - $9.38 $442,967 - $1.5 Million
159,916 Added 36.12%
602,639 $1.67 Million
Q3 2018

Nov 14, 2018

BUY
$5.53 - $11.36 $2.45 Million - $5.03 Million
442,723 New
442,723 $3.95 Million

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About IDERA PHARMACEUTICALS, INC.


  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.